THE ADVOCACY GROUP for EMERGENT BIOSOLUTIONS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 19, 2017 | $20,000 | Replaced |
| 3rd Quarter - Amendment | Oct 20, 2017 | $20,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act. NDAA - provisions related to biological and chemical defense.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J DOTCHIN | — |
Homeland Security HOM
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act. NDAA - provisions related to biological and chemical defense.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J DOTCHIN | — |
Disaster Planning/Emergencies DIS
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act. NDAA - provisions related to biological and chemical defense.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J DOTCHIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.